You just read:

Forty Seven Inc. Receives $5 Million Grant from The California Institute for Regenerative Medicine (CIRM) to Support Ongoing Clinical Trial in Acute Myeloid Leukemia

News provided by

Forty Seven Inc.

Dec 06, 2017, 07:30 ET